Sala Stampa

Latest news

maggio 30, 2017

Advanced Accelerator Applications and Blue Earth Diagnostics Announce European Manufacturing and Distribution Agreements for Axumin™ (Fluciclovine (18F)) for PET Imaging of Recurrent Prostate Cancer

AAA and Blue Earth Diagnostics Ltd., a molecular imaging diagnostics company, today announced that they have entered into a non-exclusive manufacturing agreement and an exclusive distribution agreement for the supply of Blue Earth Diagnostics’ PET imaging product Axumin™ (fluciclovine (18F)) in France, Germany, Spain, Italy, and Portugal. Axumin is indicated in Europe for use in Positron Emission Tomography (PET) imaging to detect recurrence of prostate cancer in adult men with a suspected recurrence based on elevated blood prostate specific antigen (PSA) levels after primary curative treatment.

maggio 25, 2017

Christine Mikail entra a far parte del Board of Director di Advanced Accelerator Applications

AAA ha annunciato oggi che Christine Mikail, J.D. è entrata a far parte del Board of Director della società in qualità di Direttore indipendente, non esecutiva.

Latest Press Releases

maggio 31, 2017

Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017

maggio 30, 2017

Advanced Accelerator Applications and Blue Earth Diagnostics Announce European Manufacturing and Distribution Agreements for Axumin™ (Fluciclovine (18F)) for PET Imaging of Recurrent Prostate Cancer

Upcoming Events

AAA will be present at the following events